- Gevo (GEVO) +24% on entering into a long-term agreement with HCS group.
- Tandem Diabetes Care (TNDM) +19% on Q4 earnings.
- Versum Materials (VSM) +17% as Merck KGaA offers to buy in $5.9B deal.
- Ocwen Financial (OCN) +15% on Q4 earnings.
- Sea (SE) +14% on Q4 earnings.
- Frontier Communications (FTR) +12% on Q4 earnings.
- Best Buy (BBY) +11% on Q4 earnings.
- GW Pharmaceuticals plc (GWPH) +11% on Q4 earnings.
- MercadoLibre (MELI) +10% on Q4 earnings.
- Palo Alto Networks (PANW) +10% on Q2 earnings
- Chesapeake Energy (CHK) +10% on Q4 earnings.
- Biocept (BIOC) +10% on collaboration with Providence Saint John's Health Center.
- Sarepta Therapeutics (SRPT) +7% on LGMD data.
- Denbury Resources (DNR) +6% on Q4 earnings.
- Planet Fitness (PLNT) +6% on Q4 earnings.
- Horizon Pharma (HZNP) +5% on Q4 earnings.
- Zosano Pharma Corporation (ZSAN) +5%.